Opendata, web and dolomites

AbCURE_COPD SIGNED

Antibody mediated clearance of senescent cells for treatment of COPD

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 AbCURE_COPD project word cloud

Explore the words cloud of the AbCURE_COPD project. It provides you a very rough idea of what is the project "AbCURE_COPD" about.

mediated    carry    accumulate    critical    tissues    delay    senescence    halt    groundbreaking    extend    airflow    600    strategies    age    believe    alliances    creation    companies    diabetes    million    strategic    intend    death    life    decline    model    treating    takes    poc    span    potentially    treatments    antibodies    diseases    business    firmly    evaluation    variety    group    feasibility    alone    neurodegenerative    effect    antibody    date    senescent    progression    limitations    obstructive    chronic    people    quality    fold    disease    cancer    private    europeans    treatment    idea    copd    health    implementing    clearance    multiple    acute    acronymed    fail    pave    commercialization    mouse    threatening    cardiovascular    pulmonary    abcure    significantly    10    first    osteoarthritis    applicable    medical    function    worldwide    unmet    patients    300    cells    equally    2020    revolutionary    international    lung    frequent    cure    breast   

Project "AbCURE_COPD" data sheet

The following table provides information about the project.

Coordinator
WEIZMANN INSTITUTE OF SCIENCE 

Organization address
address: HERZL STREET 234
city: REHOVOT
postcode: 7610001
website: www.weizmann.ac.il

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Israel [IL]
 Total cost 150˙000 €
 EC max contribution 150˙000 € (100%)
 Programme 1. H2020-EU.1.1. (EXCELLENT SCIENCE - European Research Council (ERC))
 Code Call ERC-2017-PoC
 Funding Scheme ERC-POC
 Starting year 2018
 Duration (year-month-day) from 2018-11-01   to  2020-04-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    WEIZMANN INSTITUTE OF SCIENCE IL (REHOVOT) coordinator 150˙000.00

Map

Leaflet | Map data © OpenStreetMap contributors, CC-BY-SA, Imagery © Mapbox

 Project objective

Chronic Obstructive Pulmonary Disease (COPD) is a group of chronic diseases characterized by airflow limitations in the lung. COPD is a critical international health problem. It is estimated to affect up to 600 million people worldwide and by 2020 it will become the third most frequent cause of death. In Europe alone, COPD affects up to 10% of people (i.e. more people than breast cancer and diabetes) and it takes the life of around 300,000 Europeans each year. Up to date, COPD has no cure as current treatments fail to halt the long-term decline in lung function. They are only able to delay its progression. Those treatments however, are associated with a variety of side effects some of which can be acute and even life threatening. Thus, COPD remains a disease with a significant unmet medical need. In this project (acronymed AbCURE_COPD) we intend to carry out a set of necessary activities for the evaluation of a potentially groundbreaking approach for treating COPD. Our approach is focusing on antibody-mediated clearance of senescent cells which accumulate in tissues with age and contribute to multiple age-related diseases, including COPD. The goal of the PoC project is two-fold. (1) The first goal is to establish the technical feasibility of our idea by testing the effect of senescence-specific antibodies on COPD development and progression by implementing COPD mouse model we developed. (2) The second goal is to establish the business feasibility of our revolutionary approach by taking the necessary steps towards its commercialization, focusing on the creation of strategic alliances with key private sector companies. We firmly believe that with our approach we can significantly extend the health span and improve the quality of life of COPD patients. Equally important, our approach will pave the way for the development of novel treatment strategies applicable to other age-related diseases, such as osteoarthritis, cardiovascular, and neurodegenerative diseases.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "ABCURE_COPD" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "ABCURE_COPD" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.1.)

EVOCELFATE (2019)

Evolution of cell fate specification modes in spiral cleavage

Read More  

Growth regulation (2019)

The wide-spread bacterial toxin delivery systems and their role in multicellularity

Read More  

SmartForests (2020)

Smart Forests: Transforming Environments into Social-Political Technologies

Read More